ArticleMaterials today. Bio2025
Smart bactericidal textile enabling in-situ visual assessment of antimicrobial activity.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Copper nanomaterial antimicrobial coatings: ion release, transparency, and wash durability across biomedical, textile, and packaging applications.Frontiers in chemistry · 2026Review
- Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital fabrics and wound dressings with antibacterial properties are essential to minimize infection risks associated with bacterial colonization of textiles. A key challenge of these materials lies in the difficulty in assessing their functional lifespan. Integrating bacterial-sensing elements into smart textiles enables real-time and in-situ evaluation of antibacterial activity. However, this approach is often hindered by the reactivity between bactericidal and bacterial-sensing components, the limited stability and selectivity of the sensing probes, and high production costs. Here, we address these challenges by presenting a smart textile that simultaneously provides antibacterial activity and bacterial-sensing capacity using a layer-by-layer sonochemical deposition method. Prussian blue, a chromogenic bacterial-sensing probe, is integrated onto hospital-grade antibacterial fabrics containing copper oxide nanoparticles. When the biocidal fabric begins to lose its antimicrobial activity, live bacteria in the textile metabolically reduce Prussian blue nanoparticles, triggering a visible colour change. This approach offers several key advantages, such as: (i) the resulting textile retains antibacterial activity comparable to conventional copper oxide-based textiles (A value > 4 in both cases); (ii) it provides a direct and visible colour transition from blue to colourless (>20 % colour losses) when the antibacterial coating begins to lose effectiveness, enabling straightforward monitoring of antibacterial lifespan without external instruments or reagents; (iii) the co-immobilization enhances coating stability, nearly doubling the binding strength of copper oxide and Prussian blue compared to single-layer coatings; and (iv), the additional Prussian blue layer significantly reduces the material cytotoxicity, enhancing biocompatibility for safer use in healthcare settings. These innovations offer a scalable, cost-effective, and multifunctional solution for infection control. The smart textile not only prevents bacterial spread but also provides timely, visual indications of coating degradation, making it a promising tool for improving patient safety in hospitals and for minimizing infection risks in schools and other high-risk environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.